Impotens forårsaget af behandling med methotrexat

Elisabeth I. Penninga; Helle Kiellberg Larsen; Stig Ejdrup Andersen

Impotens forårsaget af behandling med methotrexat

Translated title of the contribution: Impotence caused by Methotrexate treatment

Elisabeth I. Penninga, Helle Kiellberg Larsen, Stig Ejdrup Andersen

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Methotrexate (MTX) is used in the treatment of malignant and non-malignant diseases. This case report describes impotence as a seldom but possible overlooked adverse effect to MTX treatment. A 58-year-old man was treated for erythrodermia with a weekly dose of 7.5 mg MTX. He developed erective impotence 9 months after initiation of treatment. Two weeks after discontinuation of MTX the impotence subsided, but when MTX treatment was reintroduced, the impotence returned after two months. Only a few other cases of impotence associated with MTX have been described previously.

Translated title of the contribution	Impotence caused by Methotrexate treatment
Original language	Danish
Number of pages	1
Journal	Ugeskrift for laeger
Volume	170
Issue number	5
Publication status	Published - 28 Jan 2008

Cite this

@article{bec476110639476880f0e0269b6d247f,

title = "Impotens for{\aa}rsaget af behandling med methotrexat",

abstract = "Methotrexate (MTX) is used in the treatment of malignant and non-malignant diseases. This case report describes impotence as a seldom but possible overlooked adverse effect to MTX treatment. A 58-year-old man was treated for erythrodermia with a weekly dose of 7.5 mg MTX. He developed erective impotence 9 months after initiation of treatment. Two weeks after discontinuation of MTX the impotence subsided, but when MTX treatment was reintroduced, the impotence returned after two months. Only a few other cases of impotence associated with MTX have been described previously.",

author = "Penninga, {Elisabeth I.} and Larsen, {Helle Kiellberg} and Andersen, {Stig Ejdrup}",

year = "2008",

month = jan,

day = "28",

language = "Dansk",

volume = "170",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "5",

}

TY - JOUR

T1 - Impotens forårsaget af behandling med methotrexat

AU - Penninga, Elisabeth I.

AU - Larsen, Helle Kiellberg

AU - Andersen, Stig Ejdrup

PY - 2008/1/28

Y1 - 2008/1/28

N2 - Methotrexate (MTX) is used in the treatment of malignant and non-malignant diseases. This case report describes impotence as a seldom but possible overlooked adverse effect to MTX treatment. A 58-year-old man was treated for erythrodermia with a weekly dose of 7.5 mg MTX. He developed erective impotence 9 months after initiation of treatment. Two weeks after discontinuation of MTX the impotence subsided, but when MTX treatment was reintroduced, the impotence returned after two months. Only a few other cases of impotence associated with MTX have been described previously.

AB - Methotrexate (MTX) is used in the treatment of malignant and non-malignant diseases. This case report describes impotence as a seldom but possible overlooked adverse effect to MTX treatment. A 58-year-old man was treated for erythrodermia with a weekly dose of 7.5 mg MTX. He developed erective impotence 9 months after initiation of treatment. Two weeks after discontinuation of MTX the impotence subsided, but when MTX treatment was reintroduced, the impotence returned after two months. Only a few other cases of impotence associated with MTX have been described previously.

UR - http://www.scopus.com/inward/record.url?scp=40749161897&partnerID=8YFLogxK

M3 - Artikel

C2 - 18252170

AN - SCOPUS:40749161897

SN - 0041-5782

VL - 170

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 5

ER -

Impotens forårsaget af behandling med methotrexat

Abstract

Other files and links

Fingerprint

Cite this